E-LIB Suche - Ergebnisse für: Ruhnke, Leo

1

Gemtuzumab ozogamicin plus midostaurin in combination with ..:

Röllig, Christoph ; Schliemann, Christoph ; Ruhnke, Leo...
British Journal of Haematology. 204 (2024) 6 - p. 2254-2258 , 2024

Link: https://doi.org/10.1111/..

2

MDS-PB13 Score - Blood based detection of aberrancies by fl..:

Oelschlaegel, Uta ; Winter, Susann ; Sockel, Katja...
Leukemia. 38 (2024) 2 - p. 446-450 , 2024

Link: https://doi.org/10.1038/..

3

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (..:

Bill, Marius ; Ruhnke, Leo ; Zukunft, Sven...
HemaSphere. 7 (2023) S3 - p. e72156a7 , 2023

Link: https://doi.org/10.1097/..

4

Impact of BMI on patient outcome in acute myeloid leukaemia..:

Enßle, Julius C. ; Wolf, Sebastian ; Scheich, Sebastian...
British Journal of Cancer. 129 (2023) 7 - p. 1126-1133 , 2023

Link: https://doi.org/10.1038/..

5

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATIO..:

Stölzel, Friedrich ; Ruhnke, Leo ; Altmann, Heidi...
HemaSphere. 7 (2023) S3 - p. e5284457 , 2023

Link: https://doi.org/10.1097/..

6

Germ line variant GFI1-36N affects DNA repair and sensitize..:

Frank, Daria ; Patnana, Pradeep Kumar ; Vorwerk, Jan...
Blood. 142 (2023) 25 - p. 2175-2191 , 2023

Link: https://doi.org/10.1182/..

7

Midostaurin in addition to intensive chemotherapy in acute ..:

Ruhnke, Leo ; Röllig, Christoph ; Herold, Sylvia...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

8

Biallelic TET2 mutations confer sensitivity to 5′-azacitidi..:

Stölzel, Friedrich ; Fordham, Sarah E. ; Nandana, Devi...
JCI Insight. 8 (2023) 2 - p. , 2023

Link: https://doi.org/10.1172/..

9

Neue Therapieoptionen bei der Akuten Myeloischen Leukämie:

Gediga, Miriam Helena Eva ; Middeke, Jan Moritz ; Ruhnke, Leo
DMW - Deutsche Medizinische Wochenschrift. 148 (2023) 8 - p. 451-458 , 2023

Link: https://doi.org/10.1055/..

10

Secondary-type mutations do not impact outcome in NPM1-muta..:

Eckardt, Jan-Niklas ; Bill, Marius ; Rausch, Christian...
Leukemia. 37 (2023) 11 - p. 2282-2285 , 2023

Link: https://doi.org/10.1038/..

11

Prevalence and variation of CHIP in patients with aggressiv..:

Teipel, Raphael ; Kroschinsky, Frank ; Kramer, Michael...
Blood Advances. 6 (2022) 6 - p. 1941-1946 , 2022

Link: https://doi.org/10.1182/..

12

Using stroma-anchoring cytokines to augment ADCC: a phase 1..:

Berdel, Andrew F. ; Ruhnke, Leo ; Angenendt, Linus...
Blood Advances. 6 (2022) 12 - p. 3684-3696 , 2022

Link: https://doi.org/10.1182/..

13

Intensified cytarabine dose during consolidation in adult A..:

Hanoun, Maher ; Ruhnke, Leo ; Kramer, Michael...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 4611-4621 , 2022

Link: https://doi.org/10.1007/..

14

Spatial heterogeneity and differential treatment response o..:

Kunadt, Desiree ; Herold, Sylvia ; Poitz, David...
Therapeutic Advances in Hematology. 13 (2022) - p. 204062072211150 , 2022

Link: https://doi.org/10.1177/..

15

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depl..:

Ruhnke, Leo ; Stölzel, Friedrich ; Oelschlägel, Uta...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..